PMI Picard Medical, Inc.
Picard Medical (PMI) news
Picard Medical, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker PMI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Picard Medical news
We have not published a story on Picard Medical yet. When there is news, it will appear here.
Picard Medical annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.9 million | $4.4 million |
| Research and development | $3.0 million | $3.4 million |
| Net income (loss) | -$27.0 million | -$21.1 million |
| Cash from operations | -$15.7 million | -$11.9 million |
| Cash and equivalents | $7.5 million | $96,000 |
Questions about Picard Medical
What is the ticker symbol of Picard Medical?
Picard Medical, Inc. trades under the ticker PMI on NYSE.
Where is Picard Medical listed?
Picard Medical, Inc. is listed on NYSE.
Which country or territory is Picard Medical listed under?
Our directory records Picard Medical, Inc. under United States.
Does aibio.space cover Picard Medical?
aibio.space lists Picard Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Picard Medical's revenue last year?
$4.9 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Picard Medical profitable?
Picard Medical, Inc. reported a net loss of $27.0 million for the fiscal year ended Dec 31, 2025, and used $15.7 million of cash in operations, per its annual report to the SEC.
How much does Picard Medical spend on research and development?
$3.0 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Picard Medical have?
$38,000 in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: Picard Medical
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Reported a financing. SEC Form 8-K (Items 1.01,3.02,9.01). Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01,9.01). Source
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 5.03,8.01,9.01). Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
- Mergers
Filed documents for a merger or acquisition. SEC Form 425. Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 2.02,3.01,7.01,9.01). Source
- Financings
Reported a financing. SEC Form S-1. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 1.01,3.01,9.01). Source
- Financings
Reported a financing. SEC Form 8-K (Items 1.01,3.02,9.01). Source
Stock chart
Listing details
- Company
- Picard Medical, Inc.
- Ticker
- PMI
- Listing
- NYSE
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio